GILD
NASDAQ · Biotechnology
Gilead Sciences Inc
$138.36
+0.22 (+0.16%)
EPS Surprise History
Earnings Summary
Beats (Last 6)
5/6
Avg Surprise
+4.5%
Consecutive Beats
5 quarters
Latest EPS
$-6.75
YoY EPS Growth
-435.8%
History
6 quarters
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Q3 FY2026 | $-7.43 | — | — | — | — |
| Jun 30, 2026 | Q2 FY2026 | $-7.38 | $-6.75 | +$0.63 | +8.5% | Beat |
| May 7, 2026 | Q2 FY2026 | $1.94 | — | — | — | — |
| Apr 23, 2026 | Q2 FY2026 | $1.94 | — | — | — | — |
| Mar 31, 2026 | Q1 FY2026 | $1.95 | $2.03 | +$0.08 | +4.0% | Beat |
| Feb 10, 2026 | Q1 FY2026 | $1.85 | — | — | — | — |
| Dec 31, 2025 | Q4 FY2025 | $1.85 | $1.86 | +$0.01 | +0.7% | Beat |
| Sep 30, 2025 | Q3 FY2025 | $2.17 | $2.47 | +$0.30 | +13.7% | Beat |
| Jun 30, 2025 | Q2 FY2025 | $2.00 | $2.01 | +$0.01 | +0.6% | Beat |
| Mar 31, 2025 | Q1 FY2025 | $1.82 | $1.81 | -$0.01 | -0.6% | Miss |